CNS Drugs Take Longer to Develop, Win Approval

September 19, 2018

Drugs targeting the central nervous system take significantly longer to develop and get approved than other meds, according to a new analysis. In fact, the report cites that CNS drugs took 20% longer to develop and about 19 months (36%) longer on average than other meds to win FDA approval after clinical trials. 

Previous Flipbook
Optimizing Global Safety Reporting in Clinical Trials
Optimizing Global Safety Reporting in Clinical Trials

Next Flipbook
Master Protocols Can Kickstart Clinical Trials
Master Protocols Can Kickstart Clinical Trials

Request a Genetics in Clinical Trials training session

What You'll Learn